Related Experiment Video
Updated: Jun 8, 2025
06:28
E-Patient Counseling Trial E-PACO: Computer Based Education versus Nurse Counseling for Patients to Prepare for Colonoscopy
Published on: August 1, 2019
8.3K
Impact of Pharmacist Expertise on Acceptance Rates in a Comprehensive E-Consult Program within a Large Academic
Carrie Freed1, Cynthia King1, Brandon Soltesz1
1The MetroHealth System (Cleveland, OH).
Innovations in Pharmacy
|November 1, 2024
Summary
Pharmacist expertise significantly improves electronic consult (e-consult) outcomes. Integrating expert pharmacists into e-consult programs enhances recommendation acceptance rates and overall program success.
Area of Science:
- Health Informatics
- Pharmacy Practice
- Clinical Decision Support
Background:
- Electronic consults (e-consults) are common in healthcare but underutilized by pharmacy outside specific conditions.
- Limited research exists on optimizing the pharmacist's role in e-consult programs.
- This study addresses the gap by evaluating the impact of pharmacist expertise on e-consult outcomes.
Purpose of the Study:
- To assess the impact of pharmacist expertise on the outcomes of e-consults.
- To compare acceptance rates of recommendations from expert versus non-expert pharmacists.
- To analyze secondary outcomes including implementation rates and response times.
Main Methods:
- Retrospective review of 375 pharmacy e-consults from March 2020 to August 2022 at an academic health system.
- Data collected included disease state, ordering provider, pharmacist specialty, and recommendation acceptance.
- Pearson chi-square test used to compare acceptance rates between expert and non-expert pharmacists.
Main Results:
- E-consults spanned 19 disease states, with diabetes, pain management, and mental health being most common.
- Expert pharmacists had significantly higher recommendation acceptance rates (62.6%) compared to non-experts (39.6%; p=0.002).
- Overall implementation rate was 51.8%; physician assistants showed the highest acceptance rate (100.0%).
Conclusions:
- Integrating expert pharmacists into e-consult programs significantly improves recommendation acceptance.
- Comprehensive e-consult programs benefit from the inclusion of specialized pharmacist expertise.
- Findings support the expansion of pharmacist roles in digital health consultations.
Related Concept Videos
01:12Analysis of Population Pharmacokinetic Data
235
Analysis of population pharmacokinetic data involves studying the behavior of drugs within diverse populations to understand their pharmacokinetic parameters. Traditional pharmacokinetic methods typically involve collecting samples from a few individuals and estimating these parameters. While these methods are commonly used, they have limitations in capturing the variability in drug response among individuals or heterogeneous populations. Population pharmacokinetics is employed to address these...
235
01:24Factors Influencing Drug Absorption: Presystemic Elimination
183
The pharmacokinetic journey of oral drugs begins with a crucial first pass through the hepatic portal system, called the first-pass effect. This first pass significantly impacts bioavailability — the proportion of a drug that enters systemic circulation and is available for therapeutic action. The primary route sees the drug absorbed by intestinal membranes and then shunted to the liver via the hepatic portal vein. Here, pre-systemic elimination occurs as drugs face metabolism or biliary...
183
01:21Factors Affecting Drug Response: Overview
1.9K
When it comes to infants and young children, they are typically administered smaller doses of medication in comparison to adults. This is primarily because their organ functions still need to fully develop, meaning their bodies are not as efficient at metabolizing or eliminating drugs. Additionally, their blood-brain barrier is more permeable than in adults. As a result, high concentrations of drugs can easily penetrate the central nervous system (CNS), potentially leading to neurological...
1.9K
00:59Model-Independent Approaches for Pharmacokinetic Data: Noncompartmental Analysis
49
Noncompartmental analyses offer an alternative method for describing drug pharmacokinetics without relying on a specific compartmental model. In this approach, the drug's pharmacokinetics are assumed to be linear, with the terminal phase log-linear. This assumption allows for simplified analysis and interpretation of the drug's behavior in the body.
One important characteristic of noncompartmental analyses is that drug exposure increases proportionally with increasing doses. This...
One important characteristic of noncompartmental analyses is that drug exposure increases proportionally with increasing doses. This...
49
01:28Biopharmaceutics and Pharmacokinetics: Overview
1.9K
Understanding drugs, drug products, and their performance in pharmaceutical science is pivotal. Drugs, whether simple molecules or complex compounds, are designed to interact with the body's biological systems to diagnose, treat, or prevent diseases. Drug products include various delivery systems such as tablets, capsules, injections, and inhalers. The performance of these drug products is gauged by their ability to deliver the active ingredient to the desired site of action at the...
1.9K
01:06Model Approaches for Pharmacokinetic Data: Distributed Parameter Models
60
Pharmacokinetic models are mathematical constructs that represent and predict the time course of drug concentrations in the body, providing meaningful pharmacokinetic parameters. These models are categorized into compartment, physiological, and distributed parameter models.
The distributed parameter models are specifically designed to account for variations and differences in some drug classes. This model is particularly useful for assessing regional concentrations of anticancer or...
The distributed parameter models are specifically designed to account for variations and differences in some drug classes. This model is particularly useful for assessing regional concentrations of anticancer or...
60